These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32083584)
41. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease. Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275 [TBL] [Abstract][Full Text] [Related]
42. Neuroprotective effects of Danshensu in Parkinson's disease mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Han B; Che X; Zhao Y; Li C; He J; Lu Y; Wang Z; Wang T Behav Pharmacol; 2019 Feb; 30(1):36-44. PubMed ID: 29847337 [TBL] [Abstract][Full Text] [Related]
43. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model. Yang C; Mo Y; Xu E; Wen H; Wei R; Li S; Zheng J; Li W; Le B; Chen Y; Pan H; Huang S; Wang S; Wang Q Int Immunopharmacol; 2019 Oct; 75():105651. PubMed ID: 31401385 [TBL] [Abstract][Full Text] [Related]
44. Endurance Exercise Mediates Neuroprotection Against MPTP-mediated Parkinson's Disease via Enhanced Neurogenesis, Antioxidant Capacity, and Autophagy. Jang Y; Kwon I; Song W; Cosio-Lima LM; Lee Y Neuroscience; 2018 May; 379():292-301. PubMed ID: 29559387 [TBL] [Abstract][Full Text] [Related]
45. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization. Lee Y; Park HR; Chun HJ; Lee J J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261 [TBL] [Abstract][Full Text] [Related]
46. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways. Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818 [TBL] [Abstract][Full Text] [Related]
47. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease. Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269 [TBL] [Abstract][Full Text] [Related]
48. Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson's disease by targeting miR-26a-5p/DAPK1. Chen W; Hou C; Wang Y; Hong L; Wang F; Zhang J Neurosci Lett; 2022 Jun; 782():136638. PubMed ID: 35447224 [TBL] [Abstract][Full Text] [Related]
49. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents. Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118 [TBL] [Abstract][Full Text] [Related]
50. Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice. Haga H; Yamada R; Izumi H; Shinoda Y; Kawahata I; Miyachi H; Fukunaga K Pharmacol Biochem Behav; 2020 Apr; 191():172891. PubMed ID: 32126223 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model. Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472 [TBL] [Abstract][Full Text] [Related]
52. The mouse MPTP model: gene expression changes in dopaminergic neurons. Kühn K; Wellen J; Link N; Maskri L; Lübbert H; Stichel CC Eur J Neurosci; 2003 Jan; 17(1):1-12. PubMed ID: 12534964 [TBL] [Abstract][Full Text] [Related]
53. Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity. Zhou Y; Wu J; Sheng R; Li M; Wang Y; Han R; Han F; Chen Z; Qin ZH Neuroscience; 2018 Nov; 391():140-153. PubMed ID: 30195055 [TBL] [Abstract][Full Text] [Related]
54. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models. Bao XQ; Kong XC; Qian C; Zhang D Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155 [TBL] [Abstract][Full Text] [Related]
56. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model. Yang W; Chen YH; Liu H; Qu HD Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012 [TBL] [Abstract][Full Text] [Related]
57. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway. Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo. Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623 [TBL] [Abstract][Full Text] [Related]
59. Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway. Huang TT; Hao DL; Wu BN; Mao LL; Zhang J Biochem Biophys Res Commun; 2017 Dec; 493(4):1443-1449. PubMed ID: 28986252 [TBL] [Abstract][Full Text] [Related]
60. Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice. Ren Z; Yang N; Ji C; Zheng J; Wang T; Liu Y; Zuo P Neuropharmacology; 2015 Jun; 93():209-18. PubMed ID: 25680233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]